Eligibility and implementation of disease-modifying therapy for primary progressive multiple sclerosis in a UK cohort
Publication date: July 2020Source: Multiple Sclerosis and Related Disorders, Volume 42Author(s): Emma C Tallantyre, Daniel Castle, Paul Karamura, Thomas A W Brice, Fady Joseph, Katharine E Harding, Neil P Robertson
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Multiple Sclerosis | Neurology